BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24976280)

  • 1. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.
    Alboraie M; Khairy M; Elsharkawy A; Elsharkawy M; Asem N; Abo El-Seoud AR; Elghamry FG; Esmat G
    Saudi J Gastroenterol; 2014; 20(3):170-4. PubMed ID: 24976280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.
    Alboraie MA; Afifi ME; Elghamry FG; Shalaby HA; Elshennawy GE; Abdelaziz AA; Shaheen MU; Abo El-Seoud AR
    Hepat Mon; 2013; 13(6):e10810. PubMed ID: 24046790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
    Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C.
    Alboraie M; Schütte K; Khairy M; Elsharkawy M; Asem N; Elghamry F; Shalaby H; Esmat G; Malfertheiner P
    Saudi Med J; 2017 Nov; 38(11):1137-1142. PubMed ID: 29114703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
    World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
    Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
    Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing ultrasound based transient elastography cutoffs for different stages of hepatic fibrosis and cirrhosis in Egyptian chronic hepatitis C patients.
    Elsharkawy A; Alboraie M; Fouad R; Asem N; Abdo M; Elmakhzangy H; Mehrez M; Khattab H; Esmat G
    Arab J Gastroenterol; 2017 Dec; 18(4):210-215. PubMed ID: 29187317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus.
    Alboraie M; Khairy M; Elsharkawy M; Asem N; Elsharkawy A; Esmat G
    Hepatol Res; 2015 May; 45(5):560-70. PubMed ID: 24995544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients.
    Attallah AM; El-Far M; Omran MM; Farid K; Albannan MS; El-Dosoky I
    J Clin Lab Anal; 2013 Mar; 27(2):121-9. PubMed ID: 23460258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.
    Toson el-SA; Shiha GE; El-Mezayen HA; El-Sharkawy AM
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):931-9. PubMed ID: 27159125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model.
    Romagnuolo J; Andrews CN; Bain VG; Bonacini M; Cotler SJ; Ma M; Sherman M
    Scand J Gastroenterol; 2005 Nov; 40(11):1365-71. PubMed ID: 16334447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.
    Gaia S; Campion D; Evangelista A; Spandre M; Cosso L; Brunello F; Ciccone G; Bugianesi E; Rizzetto M
    Liver Int; 2015 Aug; 35(8):2027-35. PubMed ID: 25495478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.
    Arain SA; Jamal Q; Omair A
    World J Gastroenterol; 2011 Nov; 17(41):4607-13. PubMed ID: 22147967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of hepatocyte growth factor, Fas/CD95 and Endostatin for non-invasive assessment of hepatic fibrosis in biopsy-proven hepatitis C virus patients.
    Abdelgawad ME; El-Zakzok H; Salah M; El-Mezayen HA
    Infect Genet Evol; 2020 Nov; 85():104526. PubMed ID: 32890764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Güzelbulut F; Çetınkaya ZA; Sezıklı M; Yaşar B; Ozkara S; Övünç AO
    Turk J Gastroenterol; 2011 Jun; 22(3):279-85. PubMed ID: 21805418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.